Press Releases

Transportation barriers, including access to public transportation or a personal vehicle, disproportionately affect cancer survivors, particularly if they are young, uninsured or live below the poverty line, according to results of a study published today in JAMA Oncology.

A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, two commonly used breast cancer chemotherapies. The results of the large genetic analysis were published today in NPJ Breast Cancer.

Although there have been slight improvements in outcomes after conventional therapy, survival rates remain poor for women with advanced ovarian cancer. Seven researchers from Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center have been awarded pilot grants from the Ovarian Cancer SPORE to make progress in research for ovarian cancer, the fifth leading cause of cancer death in women.

Roswell Park Comprehensive Cancer Center is proud to announce that Department of Immunology researcher Kathleen Kokolus, PhD, has been named an Irish Echo “40 Under 40” awardee.

Considered the backbone of the hospital and the ones to advocate for patients all while delivering the highest quality care, the Nursing Department at Roswell Park Comprehensive Cancer Center is holding an open house on Tuesday, March 15.

Roswell Park Comprehensive Cancer Center has been named to another prestigious ranking of top cancer centers: the World’s Best Specialized Hospitals for Oncology 2022, compiled by Newsweek in collaboration with the respected research firm Statista, based on a global peer survey of healthcare professionals.

A research team led by scientists at Roswell Park Comprehensive Cancer Center has discovered a molecule that inhibits the growth and metastasis of pancreatic cancer cells through the iron metabolism pathway. Their findings, recently published in Molecular Cancer Therapeutics, pave the way toward the development of a new drug candidate for the treatment of pancreatic cancer.

Scientists from Roswell Park Comprehensive Cancer Center have shed light on a different way of overcoming mechanisms of resistance to specific therapeutic agents used to treat cancer. In a new article published in the journal Cell Reports, the researchers propose a new approach to cancer treatment based on the way different cancer cells divide.